Covid-19 impacts: Ethnic and regional inequalities in sickle cell disease patient care in Brazil
- PMID: 38058620
- PMCID: PMC10695839
- DOI: 10.1016/j.heliyon.2023.e21960
Covid-19 impacts: Ethnic and regional inequalities in sickle cell disease patient care in Brazil
Abstract
Brazil is a continental country with significant socioeconomic and ethnic inequalities. It is important to understand how these differences are reflected in health care, especially during the COVID-19 pandemic. We investigated the potential impacts of the reduced number Transcranial Doppler Ultrasound (TCD) tests performed in Brazil during the COVID-19 pandemic, and its reflections according to region and race/color for patients with Sickle Cell Disease (SCD). This study performed data queries from the Brazilian Ministry of Health, literature research, and quantitative analysis using descriptive statistical analysis. We found evidence for a decrease in the number of TCD tests performed during the pandemic (-83 %) relative to the same non-pandemic period, and disparities in tests given in five regions in Brazil. Our data show, that in absolute numbers, most people with SCD are brown, but the highest prevalence of cases was among blacks. We also found evidence for racial discrimination when performing TCD test, which leads us to believe that the Brazilian Unified Health System (SUS) may be susceptible to racism when treating this disease. The implications of these findings serve as a warning to other countries with high indices of mixed ancestry in formulating health care policies for patients with SCD.
Keywords: COVID-19; Racism; Sickle cell disease; Transcranial Doppler.
© 2023 The Authors.
Conflict of interest statement
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Figures
References
-
- Panepinto J.A., Brandow A., Mucalo L., et al. Coronavirus disease among persons with sickle cell disease, United States, march 20–may 21, 2020. Emerg. Infect. Dis. 2020;26:2473–2476. http://wwwnc.cdc.gov/eid/article/26/10/20-2792_article.htm 2020. - PMC - PubMed
-
- Dexter D., Simons D., Kiyaga C., et al. Mitigating the effect of the COVID- 19 pandemic on sickle cell disease services in African countries. The Lancet Haematology. 2020;7 https://linkinghub.elsevier.com/retrieve/pii/S2352302620301228 e430‐e432. 2020. - PMC - PubMed
-
- Brasil. Portaria no 473, de 26 de abril de 2013. Brasília, SCD: ministério da Saúde. https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=29/04/2... nal=1&pagina=59&totalArquivos=112.
-
- Enninful-Eghan H., Moore R.H., Ichord R., et al. Transcranial Doppler ultrasonography and prophylactic transfusion program is effective in preventing overt stroke in children with sickle cell disease. J. Pediatr. 2010;157:479–484. https://linkinghub.elsevier.com/retrieve/pii/S0022347610002398 2010. - PMC - PubMed
-
- Bernaudin F., Verlhac S., Peffault de Latour R., et al. Association of matched sibling donor hematopoietic stem cell transplantation with transcranial Doppler velocities in children with sickle cell anemia. JAMA. 2019;321:266. http://jama.jamanetwork.com/article.aspx?doi=10.1001/jama.2018.20059 2019. - PMC - PubMed
LinkOut - more resources
Full Text Sources
